Development of a recombinant anti-VEGFR2-EPCAM bispecific antibody to improve antiangiogenic efficiency.
Barzaman K, Samadi M, Moradi-Kalbolandi S, Majidzadeh-A K, Salehi M, Jalili N, Jazayeri MH, Khorammi S, Darvishi B, Siavashi V, Shekarabi M, Farahmand L.
Barzaman K, et al. Among authors: darvishi b.
Exp Cell Res. 2021 Aug 15;405(2):112685. doi: 10.1016/j.yexcr.2021.112685. Epub 2021 Jun 6.
Exp Cell Res. 2021.
PMID: 34090863